ProShare Advisors
ELAN icon

ProShare Advisors’s Elanco Animal Health ELAN Stock Holding History

ProShare Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$572K Sell
25,548
-1,072
-4% -$25.9K ﹤0.01% 955
2026
Q2 		$655K Sell
26,620
-1,248
-4% -$28.9K ﹤0.01% 944
2026
Q1 		$667K Sell
27,868
-1,328
-5% -$32.5K ﹤0.01% 921
2025
Q4 		$661K Sell
29,196
-2,584
-8% -$56.2K ﹤0.01% 987
2025
Q3 		$640K Buy
31,780
+19,341
+155% +$324K ﹤0.01% 981
2025
Q2 		$178K Buy
12,439
+999
+9% +$11.7K ﹤0.01% 1755
2025
Q1 		$120K Sell
11,440
-1,129
-9% -$12.8K ﹤0.01% 1798
2024
Q4 		$152K Sell
12,569
-602
-5% -$7.88K ﹤0.01% 1966
2024
Q3 		$193K Sell
13,171
-8
-0.1% -$111 ﹤0.01% 1737
2024
Q2 		$190K Sell
13,179
-4,396
-25% -$70.2K ﹤0.01% 1539
2024
Q1 		$286K Sell
17,575
-2,322
-12% -$36.3K ﹤0.01% 1454
2023
Q4 		$296K Sell
19,897
-2,833
-12% -$32.1K ﹤0.01% 1391
2023
Q3 		$255K Buy
22,730
+331
+1% +$3.84K ﹤0.01% 1307
2023
Q2 		$225K Sell
22,399
-995,494
-98% -$9.24M ﹤0.01% 1462
2023
Q1 		$9.6M Buy
+1,017,893
New +$12M 0.03% 340
2022
Q2 		– Sell
-10,842
Closed -$283K – 1894
2022
Q1 		$283K Sell
10,842
-1,068
-9% -$28.4K ﹤0.01% 1668
2021
Q4 		$338K Buy
11,910
+667
+6% +$20.7K ﹤0.01% 1713
2021
Q3 		$359K Sell
11,243
-5,897
-34% -$198K ﹤0.01% 1412
2021
Q2 		$595K Buy
17,140
+8,228
+92% +$271K ﹤0.01% 1399
2021
Q1 		$262K Buy
8,912
+391
+5% +$12K ﹤0.01% 1874
2020
Q4 		$261K Buy
+8,521
New +$260K ﹤0.01% 1703
2020
Q1 		– Sell
-8,917
Closed -$263K – 1290
2019
Q4 		$263K Buy
8,917
+141
+2% +$3.83K ﹤0.01% 1424
2019
Q3 		$233K Sell
8,776
-120
-1% -$3.6K ﹤0.01% 1357
2019
Q2 		$301K Sell
8,896
-5,819
-40% -$189K ﹤0.01% 1237
2019
Q1 		$472K Buy
+14,715
New +$453K ﹤0.01% 1036

Other funds holding ELAN

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Bowen Hanes & Co
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.43B AUM 31.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
ASR Vermogensbeheer
ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

ProShare Advisors's ELAN Position: Q3 2026 in Review

ProShare Advisors reduced its Elanco Animal Health (ELAN) stake by 4% in Q3 2026, selling an estimated $25.9K and leaving 25,548 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #955.

ProShare Advisors first reported a position in ELAN in Q1 2019 and has held it in 25 quarters since. The position peaked at $9.6M in Q1 2023. 268 funds tracked by Wall St. Rank hold ELAN as of Q3 2026.

  • ProShare Advisors held 25,548 shares of Elanco Animal Health worth $572K as of Q3 2026.
  • ProShare Advisors sold 1,072 Elanco Animal Health shares in Q3 2026, an estimated $25.9K.
  • Elanco Animal Health made up ﹤0.01% of ProShare Advisors's portfolio in Q3 2026, its #955 holding.
  • ProShare Advisors first reported a position in Elanco Animal Health in Q1 2019 and has held it in 25 quarters since.
  • ProShare Advisors's Elanco Animal Health position peaked at $9.6M in Q1 2023.
  • 268 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2026.

Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.